WeVote
Log In

Bill

Bill

SB 1256

Pharmacy Audits

2026 Regular Session Introduced by Erin Grall

SB 1256 restricts pharmacy audits by PBMs and insurers, setting notice requirements and appeals processes to reduce excessive clawbacks threatening pharmacy operations.

Introduced
#subjectindex
0
WeVote Research Nonpartisan
Bill Summary · SB 1256

Legislative bill overview

SB 1256 establishes new regulations and limitations on pharmacy audits conducted by pharmacy benefit managers (PBMs) and insurance companies in Florida. The bill sets standards for audit frequency, notice requirements, audit scope, and appeals processes for pharmacies undergoing compliance reviews.

Why is this important

Pharmacy audits have become a significant operational burden for independent and chain pharmacies, sometimes resulting in substantial clawbacks (reclaimed payments) that threaten business viability. This bill aims to balance regulatory oversight of pharmacies with protection against what many pharmacists argue are excessive or predatory audit practices by large PBMs.

Potential points of contention

  • Cost to insurers and PBMs: Stricter audit limitations and appeals processes could reduce PBMs' ability to recover allegedly overpaid claims, potentially increasing costs passed to consumers or employers
  • Pharmacy compliance standards: Opponents may argue restrictions on audits could enable fraudulent or improper billing practices to go undetected, affecting insurance program integrity
  • Scope of protections: Debate likely over whether protections apply equally to all pharmacy types (independent vs. chain) and which audit findings should be permitted versus restricted

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.